Insider trades
Kathryn C. Zoon, Director of Emergent BioSolutions EBS, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $144.5K. The latest trade was on 05/01.
Kathryn C. Zoon
Director
- Company
- Emergent BioSolutions EBS
- First filing
- 23/05/30
- Trades
- 16 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$144.5K
- Last trade
- 05/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
EBS | Open-market sale10b5-1 plan | 05/01 | 05/04 | 17,202 sh2 trades | $8.40avg. | $144,453.49 | −17.7% |
| Open-market sale10b5-1 plan | 25/08/15 | 25/08/18 | 7,086 sh | $8.87 | $62,852.82 | −9.0% | |
| Open-market sale | 25/03/12 | 25/03/12 | 10,000 sh | $5.73 | $57,300 | −18.4% | |
| Open-market sale | 24/06/04 | 24/06/06 | 10,000 sh | $6.11 | $61,100 | −15.5% | |
| Open-market sale | 24/05/29 | 24/05/31 | 1,830 sh | $4.61 | $8,436.3 | −2.8% | |
| Open-market sale | 24/05/21 | 24/05/23 | 1,089 sh | $5.78 | $6,294.42 | −2.2% | |
EBS | Open-market sale10b5-1 plan | 23/05/25–23/06/02 | 23/07/24 | 3,530 sh2 trades | $8.36avg. | $29,526.5 | −6.6% |